{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:19:46Z","timestamp":1761675586518,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jneuroim.2008.06.001","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T05:58:46Z","timestamp":1215496726000},"page":"142-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis"],"prefix":"10.1016","volume":"200","author":[{"given":"Masaharu","family":"Takamori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.06.001_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0006-3495(97)78166-9","article-title":"Functional release channel formed by the carboxyl-terminal protein of ryanodine receptor","volume":"73","author":"Bhat","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1655::AID-MUS5>3.0.CO;2-F","article-title":"Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies","volume":"21","author":"Iwasa","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1299::AID-MUS8>3.0.CO;2-6","article-title":"Ryanodine receptor gene expression thymomas","volume":"21","author":"Kusner","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib5","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1074\/jbc.M600981200","article-title":"Functional coupling between TRPC3 and RyR1 regulates the expression of key triadic proteins","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib6","first-page":"507","article-title":"Differential distribution of TRP Ca2+ channel isoforms in mouse brain","volume":"9","author":"Mori","year":"1998","journal-title":"NeuroReport"},{"issue":"74","key":"10.1016\/j.jneuroim.2008.06.001_bib7","first-page":"37","article-title":"Inositol lipids and TRPC channel activation","author":"Putney","year":"2007","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","article-title":"Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules","volume":"128","author":"Romi","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","article-title":"Striational antibodies in myasthenia gravis. Reactivity and possible clinical significance","volume":"62","author":"Romi","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(25)07050-4","article-title":"Excitation-contraction coupling in skeletal muscle","volume":"17","author":"Sandow","year":"1965","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mus.10294","article-title":"Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro","volume":"27","author":"Skeie","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib13","first-page":"187","article-title":"Immunology of ryanodine receptor and FK506 in myasthenia gravis","volume":"5","author":"Takamori","year":"2003","journal-title":"Curr. Topics Peptide Protein Res."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1212\/01.WNL.0000125254.99397.68","article-title":"Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis","volume":"62","author":"Takamori","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1468-1331.2007.01931.x","article-title":"Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders","volume":"14","author":"Takamori","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/339439a0","article-title":"Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor","volume":"339","author":"Takeshima","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib17","doi-asserted-by":"crossref","first-page":"21617","DOI":"10.1074\/jbc.M202549200","article-title":"Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition","volume":"277","author":"Trebak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib18","doi-asserted-by":"crossref","first-page":"8675","DOI":"10.1074\/jbc.273.15.8675","article-title":"The membrane topography of human transient receptor potential 3 as inferred from glycosylation-scanning mutagenesis and epitope immunocytocheminstry","volume":"273","author":"Vannier","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BJ20071504","article-title":"TRPC3-interacting triadic proteins in skeletal muscle","volume":"411","author":"Woo","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.jneuroim.2008.06.001_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(00)81233-7","article-title":"trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry","volume":"85","author":"Zhu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2008.06.001_bib21","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(19)39968-5","article-title":"Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum","volume":"265","author":"Zorzato","year":"1990","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:09:03Z","timestamp":1759046943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0165572808001835"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}